XOMA Corp (NASDAQ:XOMA)
| 21.10 Delayed Data As of Jan 27 |  -0.14 / -0.66%Today’s Change | 15.68 Today|||52-Week Range 32.09 | +14.67% Year-to-Date |
Latest XOMA News | Press Releases
No recent news for XOMA Corp.
Today’s Trading
| Previous close | 21.24 |
| Today’s open | 20.53 |
| Day’s range | 20.53 - 21.20 |
| Volume | 323 |
| Average volume (3 months) | 20,954 |
| Market cap | $246.5M |
Data as of 3:57pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -16.27% |
| Earnings growth (this year) | -402.31% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +29.86% |
| P/E ratio | 25.1 |
| Price/Sales | 6.66 |
| Price/Book | 1.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XXII22nd Century Group I... | -0.05 | -4.35% |
| LCTXLineage Cell Therape... | -0.01 | -0.71% |
| RCELAVITA Medical Inc | 0.00 | 0.00% |
| ---- |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | March 8, 2023 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $38.2M |
| Annual profit (last year) | $12.3M |
| Net profit margin | 32.36% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
